Resultats de la cerca - Brian Gadbaw
- Mostrar 1 - 7 resultats de 7
-
1
-
2
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study per Alì Taher, Zeynep Karakaş, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyère Mahuzier, Brian Gadbaw, Yeşim Aydınok
Publicat 2017Carta -
3
Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study per Alessandro M. Vannucchi, Srđan Verstovšek, Paola Guglielmelli, Martin Grießhammer, Timothy C. Burn, Ahmad Naim, Dilan Paranagama, Mahtab Marker, Brian Gadbaw, Jean‐Jacques Kiladjian
Publicat 2017Artigo -
4
-
5
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues per Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, Brian Gadbaw, Li Jiang, Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell Öberg
Publicat 2015Artigo -
6
Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy per David Delgado, Jacquelyn A. Hank, Jill Kolesar, David Lorentzen, Jacek Gan, Songwon Seo, KyungMann Kim, Suzanne Shusterman, Stephen D. Gillies, Ralph A. Reisfeld, Richard K. Yang, Brian Gadbaw, Kenneth DeSantes, Wendy B. London, Robert C. Seeger, John M. Maris, Paul M. Sondel
Publicat 2010Artigo -
7
Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study per Suzanne Shusterman, Wendy B. London, Stephen D. Gillies, Jacquelyn A. Hank, Stephan D. Voss, Robert C. Seeger, C. Patrick Reynolds, Jennifer Kimball, Mark R. Albertini, Barrett Wagner, Jacek Gan, Jens C. Eickhoff, Kenneth DeSantes, Susan L. Cohn, Toby T. Hecht, Brian Gadbaw, Ralph A. Reisfeld, John M. Maris, Paul M. Sondel
Publicat 2010Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Astrobiology
Bone marrow
Gastroenterology
Refractory (planetary science)
Myelofibrosis
Physics
Ruxolitinib
Adverse effect
Biology
Cancer research
Gene
Genetics
Surgery
Acromegaly
Allele
Alternative medicine
Antibody
Antigen
Beta thalassemia
Carcinoid syndrome
Cell culture
Chemotherapy
Clinical trial
Complication
Corticosteroid
Crossover study
Genotype
Graft-versus-host disease